View in EDS HTML Full Text PDF Full Text

Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.

Saved in:
Bibliographic Details
Title: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
Authors: Strojnik K; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Blatnik A; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; University of Ljubljana, Ljubljana, Slovenia., Krajc M; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; University of Ljubljana, Ljubljana, Slovenia., Novaković A; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Ignjatović M; Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Ocvirk J; Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Stegel V; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Škerl P; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Klančar G; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Novaković S; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia., Šetrajčič Dragoš V; University of Ljubljana, Ljubljana, Slovenia. vsetrajcic@onko-i.si.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. vsetrajcic@onko-i.si.
Source: BJC reports [BJC Rep] 2026 Feb 16; Vol. 4 (1), pp. 5. Date of Electronic Publication: 2026 Feb 16.
Publication Type: Journal Article
Journal Info: Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918752188106676 Publication Model: Electronic Cited Medium: Internet ISSN: 2731-9377 (Electronic) Linking ISSN: 27319377 NLM ISO Abbreviation: BJC Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41699384
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Strojnik+K%22">Strojnik K</searchLink>; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Blatnik+A%22">Blatnik A</searchLink>; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; University of Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Krajc+M%22">Krajc M</searchLink>; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.; University of Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Novaković+A%22">Novaković A</searchLink>; Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Ignjatović+M%22">Ignjatović M</searchLink>; Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Ocvirk+J%22">Ocvirk J</searchLink>; Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Stegel+V%22">Stegel V</searchLink>; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Škerl+P%22">Škerl P</searchLink>; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Klančar+G%22">Klančar G</searchLink>; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Novaković+S%22">Novaković S</searchLink>; University of Ljubljana, Ljubljana, Slovenia.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia.<br /><searchLink fieldCode="AU" term="%22Šetrajčič+Dragoš+V%22">Šetrajčič Dragoš V</searchLink>; University of Ljubljana, Ljubljana, Slovenia. vsetrajcic@onko-i.si.; Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia. vsetrajcic@onko-i.si.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229918752188106676%22">BJC reports</searchLink> [BJC Rep] 2026 Feb 16; Vol. 4 (1), pp. 5. <i>Date of Electronic Publication: </i>2026 Feb 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Portfolio%22">Nature Portfolio </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9918752188106676 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2731-9377 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2227319377%22">27319377 </searchLink><i>NLM ISO Abbreviation: </i>BJC Rep <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41699384
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s44276-026-00206-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 5
    Titles:
      – TitleFull: Cosegregation analysis following an excellent response to olaparib in a pancreatic cancer patient carrier of BRCA2:c.7892 T > C variant enables its reclassification from VUS to pathogenic.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Strojnik K
      – PersonEntity:
          Name:
            NameFull: Blatnik A
      – PersonEntity:
          Name:
            NameFull: Krajc M
      – PersonEntity:
          Name:
            NameFull: Novaković A
      – PersonEntity:
          Name:
            NameFull: Ignjatović M
      – PersonEntity:
          Name:
            NameFull: Ocvirk J
      – PersonEntity:
          Name:
            NameFull: Stegel V
      – PersonEntity:
          Name:
            NameFull: Škerl P
      – PersonEntity:
          Name:
            NameFull: Klančar G
      – PersonEntity:
          Name:
            NameFull: Novaković S
      – PersonEntity:
          Name:
            NameFull: Šetrajčič Dragoš V
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 16
              M: 02
              Text: 2026 Feb 16
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 2731-9377
          Numbering:
            – Type: volume
              Value: 4
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: BJC reports
              Type: main
ResultId 1